40.46
First Tracks Biotherapeutics Inc Aktie (TRAX) Neueste Nachrichten
TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC - mexc.co
First Tracks Biotherapeutics Director Sold Shares Worth Over $1.7M - TradingView
First Tracks Biotherapeutics (TRAX) director sells shares after option exercise - Stock Titan
H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $57 - Moomoo
TRAX Reiterates by First Tracks -- Price Target Maintained at $5 - GuruFocus
Long term debt to total assets ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Which stocks are gapping on Wednesday? - ChartMill
Cash flow from operating activities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
EBIT per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
After tax other income/expense of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Announces Participation in September Investor Conferences - finance.yahoo.com
Non-controlling/minority interest of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total liabilities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Taxes of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Diluted shares outstanding of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Total operating expenses of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Diluted earnings per share (diluted EPS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics, Inc. Revenue Breakdown – NASDAQ:TRAX - TradingView
Total revenue of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Dilution adjustment of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Price to cash flow ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
CapEx per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Number of shareholders of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Enterprise value to EBITDA forward of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Net debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Gross profit of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
EBIT of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Net current asset value per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Free cash flow of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total liabilities & shareholders' equities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Enterprise value to EBITDA ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
EBITDA per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Enterprise value to EBIT forward of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Operating expenses (excl. COGS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Diluted net income available to common stockholders of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
AnaptysBio, Inc. (ANAB) Earnings Preview: The First Full Royalty-Model Quarter Matters More Than the Headline EPS - AlphaStreet
J.P. Morgan Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $65 - Moomoo
Piper Sandler Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $95 - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
First Tracks Biotherapeutics CBO Benjamin Stone Receives 60,492 Performance Stock Units - Kalkine Media
First Tracks Biotherapeutics' CMO Paul F. Lizzul Earns 60,492 Performance Stock Units Following Certified Milestones - Kalkine Media
First Tracks Biotherapeutics CEO Daniel Faga Awarded 193,575 Performance Stock Units - Kalkine Media
First Tracks (TRAX) insider records new share trades - Stock Titan
First Tracks Biotherapeutics (TRAX) insider updates holdings - Stock Titan
First Tracks Biotherapeutics (TRAX) insider logs trades - Stock Titan
FIRST TRACKS BIOTHERAPEUTICS INC : JP MORGAN RAISES TARGET PRICE TO $65 FROM $30 - Moomoo
Wolfe Research Begins Coverage on First Tracks Biotherapeutics (NASDAQ:TRAX) - MarketBeat
Wolfe Research initiates First Tracks stock with outperform rating By Investing.com - Investing.com Canada
We're Hopeful That First Tracks Biotherapeutics (NASDAQ:TRAX) Will Use Its Cash Wisely - Sahm
Why Did CRCL Stock Lose Steam? Wall Street Split On Circle’s Banking Win - Stocktwits
AnaptysBio earnings ahead: First results as royalty company By Investing.com - Investing.com Australia
AnaptysBio earnings ahead: First results as royalty company - Investing.com
First Tracks Biotherapeutics (NASDAQ: TRAX) Share Price, TRAX Stock News, TRAX Share Price & Updates - kalkine.ca
TRAX SEC FilingsFirst Tracks Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
First Tracks Biotherapeutics, Inc. Stock 12‑Month Price Target Raised to $63.38, Implies 37% Upside - TradingView
Piper Sandler raises First Tracks stock price target on pipeline progress - Investing.com Australia
TRAX Maintained by First Tracks -- Price Target Raised to $95.00 - GuruFocus
First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results - Benzinga
A Quick Look at Today's Ratings for First Tracks Biotherapeutics(TRAX.US), With a Forecast Between $57 to $95 - Moomoo
TRAX Maintained by HC Wainwright & Co. -- Price Target Raised to $57.00 - GuruFocus
Wedbush Adjusts PT on First Tracks Biotherapeutics to $70 From $60, Maintains Outperform Rating - marketscreener.com
First Tracks Biotherapeutics, Inc. Stock 12‑Month Price Target Raised to $60.5, Implies 31% Upside - tradingview.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):